Explore chapters and articles related to this topic
Pediatric Imaging in General Radiography
Published in Christopher M. Hayre, William A. S. Cox, General Radiography, 2020
Allen Corrall, Joanna Fairhurst
Dyskinetic cerebral palsy is sometimes used to describe the resulting disability from HIE. The child suffers from involuntary movements such as dystonia (twisting and repetitive movements) or athetosis, (slow writhing movements of limbs) (South & Isaacs, 2012).
Cerebral palsy
Published in James Law, Alison Parkinson, Rashmin Tamhne, David Hall, Communication Difficulties in Childhood, 2017
Children with spastic quadriplegia (affecting all four limbs, the trunk, oral and pharyngeal muscles), who account for around 8% of the population, are often totally dependent. They frequently have severe learning difficulties, seizures and sensory impairments, which in combination with bulbar problems lead to profound communication impairments. Dyskinetic cerebral palsy (approximately 10%) is characterised by ¯uctuating tone throughout the body, often with involuntary movements. Bulbar problems are very common, often evidenced by early feeding difficulties, leading to dysarthric speech. The majority of children have normal intelligence or mild learning difficulties. Epilepsy or visual problems are not common.
The neonate
Published in Louise C Kenny, Jenny E Myers, Obstetrics, 2017
Brain MRI findings are associated with specific outcomes: basal ganglia injury is associated with dyskinetic cerebral palsy (CP); internal capsule injury is associated with upper motor lesions (e.g. spastic hemiplegia); cerebral cortex injury is associated with learning difficulties.
Attainment of personal goals in the first year of intrathecal baclofen treatment in dyskinetic cerebral palsy: a prospective cohort study
Published in Disability and Rehabilitation, 2023
Laura A. Bonouvrié, Helga Haberfehlner, Jules G. Becher, Johan S. H. Vles, R. Jeroen Vermeulen, Annemieke I. Buizer
Our previous trial, the Intrathecal baclofen in DYSkinetic cerebral palsy (IDYS) trial, provided level II evidence for the beneficial effect of ITB in individuals with severe dyskinetic CP (GMFCS level IV and V) on attainment of individual treatment goals, after three months of blinded treatment [8]. However, high level evidence on the longer term for attainment of individual treatment goals is still lacking. The primary aim of the current study was therefore to evaluate the effect on attainment of individual goals in daily life one year after pump implantation in children and adolescents with dyskinetic CP. Secondary aims were: (1) to address the effects on secondary outcome measures (dystonia, choreoathetosis, spasticity, pain, comfort, functional skills, and range of motion (ROM)); (2) to identify factors that are associated with the attainment of individual treatment goals; (3) to report complications within the first year after pump implantation.
The impact of botulinum toxin type A in the treatment of drooling in children with cerebral palsy secondary to Congenital Zika Syndrome: an observational study
Published in Neurological Research, 2021
Henrique F Sales, Caroline Cerqueira, Daniel Vaz, Débora Medeiros-Rios, Giulia Armani-Franceschi, Pedro H Lucena, Carla Sternberg, Ana C Nóbrega, Cleber Luz, Danilo Fonseca, Alessandra L Carvalho, Larissa Monteiro, Isadora C Siqueira, Igor D Bandeira, Rita Lucena
The defining diagnostic criterion was Spastic or Dyskinetic Cerebral Palsy, the presence of motor deficits associated with non-progressive spasticity or involuntary movements affecting functional capacity and arising from pre-, peri- or post-natal brain injury that occurred prior to 2 years of age. The defining diagnostic criterion for CZS took account of the criteria used by França et al. [6] for the selection of highly probable cases: neuroimaging examination (computed tomography and/or MRI of the brain) suggestive of congenital infection (cerebral calcifications, ventricular enlargement or both) and negative tests for other congenital infections (cytomegalovirus, rubella, toxoplasmosis and syphilis). Children who met the following criteria were therefore eligible for selection: (1) born to mothers whose pregnancies occurred at the time of the ZIKV epidemic in Brazil (date of birth after June 2015); (2) manifesting the above-mentioned criteria for probable CZS; and (3) whose mothers had a rash during pregnancy, to reinforce the association with a potential ZIKV infection during pregnancy.
Eye-gaze control technology holds the potential to promote communication skills in young children with dyskinetic cerebral palsy, but more rigorous research is needed to prove its effectiveness1
Published in Evidence-Based Communication Assessment and Intervention, 2019
Participants: Participants were five children ranging from 3 to 5 years of age. The children were diagnosed with dyskinetic cerebral palsy. Inclusion criteria included higher receptive than expressive language as reported by their caregivers; speech function classified at Viking Speech Scale Levels III–IV and Levels IV–V on the Communication Function Classification System, Gross Motor Function Classification Systems – Expanded and Revised, and Manual Ability Classification System. Additional inclusion criteria included the ability to maintain a stable seating position, and to successfully maintain and shift eye fixation, and an emergent yes/no response evaluated using parent report and clinician assessment.